ClinVar Miner

Submissions for variant NM_001323289.2(CDKL5):c.2579_2582dup (p.Leu862fs)

dbSNP: rs2147178955
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001389577 SCV001590972 pathogenic Developmental and epileptic encephalopathy, 2; Angelman syndrome-like 2020-09-20 criteria provided, single submitter clinical testing This variant disrupts the C-terminus of the CDKL5 protein. Other variant(s) that disrupt this region (NM_001323289.1:c.2828_2829del, p.Arg943fs*11) have been determined to be pathogenic (PMID: 29444904). This suggests that variants that disrupt this region of the protein are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with CDKL5-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu862Alafs*49) in the CDKL5 gene. It is expected to result in an absent or disrupted protein product.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.